Can the Uterine Microbiome Affect IVF Implantation? What New 2026 Research Means for Fertility and Surrogacy

New fertility research is exploring whether the uterine microbiome the community of microorganisms associated with the uterus and its lining may influence embryo implantation.

A 2026 study found that certain Lactobacillus bacteria were associated with a healthier uterine environment. Laboratory and animal experiments also suggested that a bacteria-derived “postbiotic” could reduce signs of inflammation and aging in the uterine lining.

The research is promising, but it does not prove that probiotics or postbiotics improve IVF success in people. The findings are preliminary, and the experimental treatment has not been tested as a fertility treatment in human clinical trials or surrogacy pregnancies.

Here is what researchers discovered, what remains unknown, and what the findings may eventually mean for IVF and surrogacy.

Certain species of bacteria in the uterus appear to support fertility and combat age-related decline.

(Image credit: anusorn nakdee via Getty Images)

What Is the Uterine Microbiome?

The uterine microbiome refers to microorganisms that may be present in or associated with the uterus and its inner lining, known as the endometrium.

During an IVF embryo transfer, an embryo is placed inside the uterus. It must then attach to the endometrium and continue developing. The ability of the uterine lining to support this process is called endometrial receptivity.

Researchers have increasingly investigated whether the reproductive microbiome may be connected to:

• Endometrial health

• Inflammation in the uterus

• Embryo implantation

• Pregnancy outcomes

• Age-related changes in uterine receptivity

Some research has associated Lactobacillus-dominant reproductive environments with positive fertility outcomes. However, scientists have not established one universal definition of a “healthy” uterine microbiome, and the presence of particular bacteria does not guarantee that an embryo will implant.

What Did the 2026 Uterine Microbiome Study Find?

The study, published in Cell Host & Microbe, examined endometrial samples from 149 women ages 20 to 45 who were undergoing fertility treatment in China.

According to a report published by Live Science, the researchers found that older participants had lower levels of particular Lactobacillus bacteria, especially Lactobacillus gasseri and Lactobacillus crispatus.

Of the participants, 93 later underwent IVF and 56 became pregnant. Those who became pregnant had higher levels of Lactobacillus in their uterine lining than those who did not.

This finding shows an association, but it does not prove that the bacteria caused implantation or pregnancy. Other differences among patients may have contributed to their outcomes.

The researchers then conducted experiments using human uterine cells and older mice. They focused on L. gasseri and an exopolysaccharide—a sugar molecule produced by the bacterium. The purified bacteria-derived substance was described as a postbiotic called LG-EPS.

In experimental models, L. gasseri and LG-EPS were associated with:

• Reduced inflammation and oxidative stress

• Fewer signs of aging in the uterine lining

• Changes in a cellular pathway involved in tissue growth and repair

• Higher embryo implantation rates in treated older mice

• Improved signs of receptivity in artificially aged human uterine cells

These findings give researchers a possible biological pathway to investigate. They do not yet demonstrate that LG-EPS is safe or effective as a fertility treatment for people.

What Is a Postbiotic?

A postbiotic is a substance or byproduct produced by microorganisms. Unlike probiotics, postbiotics do not contain live bacteria.

A simple comparison is:

• Probiotics: Live microorganisms intended to support a particular microbial environment

• Prebiotics: Substances that provide nutrients for certain microorganisms

• Postbiotics: Compounds or byproducts produced by microorganisms

In the 2026 study, researchers examined an exopolysaccharide produced by L. gasseri. Because it came from the bacterium but did not contain live L. gasseri, it was studied as a postbiotic.

Postbiotics may eventually be easier to standardize than treatments containing live bacteria. Nevertheless, LG-EPS remains experimental. It is not an approved IVF medication, implantation treatment, or recommended surrogacy supplement.

Can a Postbiotic Improve IVF Implantation?

Researchers do not know yet.

The study provides early evidence from endometrial samples, laboratory-grown cells, and mice. It did not test whether giving LG-EPS to people before an embryo transfer increases implantation, clinical pregnancy, ongoing pregnancy, or live birth rates.

Before a postbiotic could become part of fertility treatment, human clinical trials would need to determine:

• Whether the treatment is safe

• Which patients might benefit

• What dose and method of administration should be used

• Whether it improves implantation and live birth rates

• Whether it interacts with fertility medications

• Whether it could unintentionally disrupt the reproductive microbiome

For now, the findings should be viewed as a promising scientific direction rather than an available fertility treatment.

Do Probiotics Improve IVF Success?

There is not currently enough evidence to conclude that over-the-counter probiotics improve IVF implantation or live birth rates.

The study did not test commercially available probiotic supplements. It investigated specific bacteria and a purified substance produced by L. gasseri under controlled experimental conditions.

Different probiotic products contain different bacterial strains and doses. Oral probiotics, vaginal products, and laboratory-developed postbiotics are not interchangeable and may affect the body differently.

Patients and surrogates should not begin using probiotics, postbiotics, supplements, or vaginal products to improve implantation without first consulting the fertility physician managing the embryo-transfer cycle.

“Natural” or nonprescription does not automatically mean that a product is appropriate during IVF or pregnancy.

How Could the Uterine Microbiome Affect Embryo Implantation?

Researchers believe that the uterine environment may influence inflammation, immune activity, cellular aging, and tissue repair. These processes could potentially affect the endometrium’s ability to support an implanting embryo.

In the new study, L. gasseri and its postbiotic appeared to influence a cellular signaling pathway involved in cell growth and tissue repair. The treatment reduced signs of inflammation and aging in experimental models.

However, implantation is a complex process. It depends on numerous factors, including:

• Embryo development and chromosomal competence

• The timing of the embryo transfer

• Endometrial preparation and hormone levels

• Uterine anatomy and health

• The medical history of the person carrying the pregnancy

• Other biological factors that may not always be identifiable

The uterine microbiome may eventually prove to be one part of this larger picture, but it cannot currently explain every unsuccessful embryo transfer.

What Does This Research Mean for IVF and Surrogacy?

Embryo implantation is a critical milestone in both conventional IVF and gestational surrogacy.

During a surrogacy journey, an embryo created through IVF is transferred to the surrogate’s uterus. The fertility clinic prepares and monitors the surrogate’s uterine lining before determining whether she is medically ready for the transfer.

Research into endometrial health is therefore relevant to future surrogacy care. However, this particular study was not conducted specifically on surrogates, and it does not establish a new screening requirement or medical protocol for surrogacy journeys.

For intended parents, the practical takeaway is not to request a postbiotic treatment. Instead, the study illustrates why IVF and embryo-transfer decisions should be made by qualified reproductive endocrinologists using each patient’s and surrogate’s individual medical information.

For surrogates, all medications, supplements, probiotics, and vaginal products should be disclosed to the fertility clinic. The clinic’s instructions should be followed before, during, and after the embryo-transfer cycle.

Does the Uterine Microbiome Explain an Unsuccessful Embryo Transfer?

No single factor explains every unsuccessful transfer.

An embryo may not implant for reasons involving the embryo, uterine environment, transfer timing, hormone levels, or other medical and biological variables. In some cases, a clear reason is never identified.

The microbiome study investigates one possible part of the implantation process. It should not be used to conclude that an unsuccessful transfer occurred because a surrogate or patient lacked beneficial bacteria.

It also does not prove that changing the uterine microbiome would have prevented the outcome.

After an unsuccessful transfer, the fertility physician can review the complete cycle, discuss possible contributing factors, and determine whether additional evaluation or a different protocol may be appropriate.

Should Intended Parents Request Uterine Microbiome Testing?

There is not yet a universally accepted uterine microbiome test that can guarantee implantation or identify the correct treatment for every IVF patient.

Some clinics may offer microbiome-related or endometrial tests, but availability does not necessarily mean that a test has been proven to improve live birth rates.

Before agreeing to testing, intended parents can ask their fertility clinic:

1. Is uterine microbiome testing recommended for our specific circumstances?

2. What evidence supports this test?

3. Will the result change the medical treatment plan?

4. Has the test been shown to improve live birth rates?

5. Is it considered standard care or an experimental IVF add-on?

6. What are its costs, limitations, and potential risks?

7. Should the surrogate avoid any supplements or vaginal products before transfer?

These questions can help intended parents distinguish between emerging research and treatments that are already supported by clinical evidence.

Could This Research Lead to New Fertility Treatments?

Possibly, but additional research is needed.

The study provides scientists with a potential target for treating age-related changes in the endometrium. Future studies may investigate whether carefully developed postbiotics can improve the uterine environment before embryo transfer.

Researchers will need to conduct human clinical trials involving diverse patient populations. Those trials must evaluate safety and meaningful fertility outcomes—not only changes in cells or microbiome composition.

The most important outcomes will include implantation, ongoing pregnancy, pregnancy complications, and live birth rates.

Until those studies are completed, patients should be cautious of products or services claiming to “balance” the uterine microbiome or guarantee better IVF outcomes.

How Does ACRC Surrogacy Support the IVF and Embryo-Transfer Process?

The fertility clinic—not the surrogacy agency—makes medical decisions about testing, medication, endometrial preparation, embryo transfer, and pregnancy care.

ACRC Surrogacy helps intended parents navigate the wider surrogacy journey and coordinate with the professionals involved. Depending on the individual journey, this may include supporting communication among:

• Intended parents

• The surrogate

• Fertility clinics

• Reproductive attorneys

• Insurance professionals

• Escrow providers

• Other members of the surrogacy team

Clear coordination helps intended parents and surrogates understand medical timelines, responsibilities, instructions, and the next steps before and after embryo transfer.

Frequently Asked Questions About the Uterine Microbiome and IVF

Can the uterine microbiome affect IVF implantation?

Early studies suggest that there may be an association between certain uterine bacteria, endometrial receptivity, and pregnancy outcomes. Researchers have not yet proven that changing the uterine microbiome improves IVF implantation or live birth rates.

Which bacteria did the 2026 study examine?

The researchers focused particularly on Lactobacillus gasseri and a bacteria-derived exopolysaccharide called LG-EPS. They also identified age-related differences involving Lactobacillus crispatus.

Is LG-EPS currently available as an IVF treatment?

No. LG-EPS is an experimental postbiotic studied in cells and mice. It has not been established as a safe or effective fertility treatment for people.

Should someone take probiotics before an embryo transfer?

Patients and surrogates should not start a probiotic, supplement, or vaginal product specifically to improve implantation without consulting their fertility physician. An over-the-counter probiotic will not necessarily reproduce the study’s experimental findings.

Was the research conducted on surrogates?

No. The human portion involved women undergoing fertility treatment in China. The experimental treatment work involved laboratory-grown uterine cells and mice. It did not test a postbiotic treatment in surrogates or surrogacy pregnancies.

Could the research change surrogacy protocols?

Not yet. The findings may support future research into endometrial preparation, but they do not currently establish a new screening or treatment protocol for surrogates.

Promising Research—but Not Yet a Fertility Treatment

The uterine microbiome is an emerging area of reproductive research. The 2026 study offers an intriguing explanation of how a bacteria-derived substance might influence inflammation, cellular aging, and endometrial receptivity.

The findings may eventually contribute to more personalized IVF and embryo-transfer care. For now, the responsible conclusion is measured: the research is encouraging but preliminary.

It should not lead intended parents or surrogates to begin taking probiotics, postbiotics, supplements, or other products without guidance from the fertility professionals managing their journey.

If you are considering surrogacy and want to understand the IVF, matching, medical, legal, and coordination process, ACRC Surrogacy is here to help you plan your next steps.

Book a free consultation with ACRC Surrogacy and speak with our team about your path to parenthood.

Medical Disclaimer

This article is provided for general educational and informational purposes only. It is not medical advice and should not be used to diagnose a condition, select a treatment, change an IVF or embryo-transfer protocol, or replace consultation with a qualified physician.

Fertility and surrogacy care should be individualized. Intended parents and surrogates should consult their reproductive endocrinologist or another licensed healthcare professional before using any medication, supplement, probiotic, postbiotic, or vaginal product. Research findings and medical guidance may change as additional evidence becomes available.

Sources

• Ishtiaq, I. “Bacterial ‘postbiotic’ may help preserve fertility in the aging uterus, preliminary research suggests.” Live Science, August 7, 2026. Read the cited article.

• Li, M., et al. “Lactobacillus gasseri postbiotics ameliorate age-related decline in endometrial receptivity.” Cell Host & Microbe (2026). View the original research.